Leptin and Ghrelin in Relation to Helicobacter Pylori Status in Adult Males
Overview
Authors
Affiliations
Context: Leptin and ghrelin, hormones involved in human energy homeostasis, are both produced in the stomach.
Objective: We sought to determine whether the presence of Helicobacter pylori affects gastric and systemic levels of leptin and ghrelin.
Design, Setting, And Patients: We consecutively enrolled 256 patients referred for upper endoscopy at a Veterans Affairs outpatient endoscopy center.
Outcomes: We obtained fasting serum, fundic and antral biopsies, and gastric juice. Based on histological, biochemical, and serological assays, patients were categorized as H. pylori+ or H. pylori-. Leptin and total ghrelin levels in serum, gastric biopsies, and gastric juice were determined by specific ELISAs.
Results: Of the 256 subjects, 120 were H. pylori+ and 96 were H. pylori-; 40 patients of indeterminate status were excluded. Serum and fundic leptin levels correlated with body mass index in the H. pylori+ (r = 0.35; P < 0.0001 and r = 0.35; P < 0.0001, respectively) and H. pylori- (r = 0.65; P < 0.0001 and r = 0.41; P < 0.0001, respectively) groups, but H. pylori+ subjects had significantly lower serum leptin levels [median 2.2 ng/ml (interquartile range 0.9-4.6) vs. 4.0 ng/ml (1.7-7.2); P = 0.0003]. Serum ghrelin levels were similar in the H. pylori+ and H. pylori- groups [median 1651 pg/ml (interquartile range 845-2247) vs. 1629 pg/ml (992-2886); P = 0.23]. H. pylori status did not significantly affect gastric biopsy leptin and ghrelin levels. Ghrelin levels in gastric juice varied over 4 log(10) (<80-776,000 pg/ml) and correlated with gastric juice pH in the H. pylori+ group (r = 0.68; P < 0.0001).
Conclusions: These findings provide evidence that H. pylori status affects leptin and ghrelin homeostasis, presumably via intragastric interactions.
Active Infection Does Not Influence Outcomes After Sleeve Gastrectomy-Observational Cohort Study.
Lukasiewicz M, Lisovski P, Proczko-Stepaniak M, Wilczynski M, Szarafinska M, Swietlik D J Clin Med. 2025; 14(1.
PMID: 39797191 PMC: 11721997. DOI: 10.3390/jcm14010109.
Tang C, Zhang Q, Zhang C, Du X, Zhao Z, Qi W Cardiovasc Diabetol. 2024; 23(1):441.
PMID: 39695657 PMC: 11657082. DOI: 10.1186/s12933-024-02536-0.
Emini M, Bhargava R, Aldhwayan M, Chhina N, Rodriguez Flores M, Aldubaikhi G J Endocr Soc. 2024; 9(1):bvae214.
PMID: 39659543 PMC: 11631353. DOI: 10.1210/jendso/bvae214.
, esophageal precancerous lesions, and proton pump inhibitor overuse.
Zhang F, Zhang H, Liu Y, Tang F World J Gastroenterol. 2024; 30(42):4591-4596.
PMID: 39563751 PMC: 11572623. DOI: 10.3748/wjg.v30.i42.4591.
Qin Y, Yao S, Wang G, Xu Z, Zhu G, Li Y J Inflamm Res. 2024; 17:6439-6452.
PMID: 39310898 PMC: 11414752. DOI: 10.2147/JIR.S475352.